Active ingredientUlifloxacinCat. No. P-U004-001CAS 112984-60-8Family · Pharmaceutical analytical standards
Ulifloxacin
A fluoroquinolone that is the active form of prulifloxacin: the prodrug, patented in Japan in 1987 and approved there in 1997, is converted in the body into ulifloxacin, used against urinary tract infections and flare-ups of chronic bronchitis. This family brings together the active ingredient, metabolites and labelled standards.
Did you know?The enzyme that releases ulifloxacin from the prodrug is mainly paraoxonase, a blood enzyme that travels with HDL cholesterol and was discovered through its ability to neutralise some organophosphorus pesticides.
Go to the active ingredient →Active ingredientUlifloxacinCat. No. P-U004-001CAS 112984-60-8
MetaboliteUlifloxacin Acyl GlucuronideCat. No. P-U004-002CAS 172040-93-6
Isotopically labelledUlifloxacin-d8Cat. No. P-U004-003CAS 1246820-95-0No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.